Role of the target organ in determining susceptibility to experimental autoimmune myasthenia gravis

Journal of Neuroimmunology

Volumn 89, Issue 1-2, 1998, Pages 131-141

  Hoedemaekers, A ^a   Bessereau, J L ^b   Graus, Y ^c   Guyon, T ^d   Changeux, J P ^b   Berrih Aknin, S ^d   Van Breda Vriesman, P ^a   De Baets, Marc H ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b INSTITUT PASTEUR   (France)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d CNRS   (France)

Author keywords

Acetylcholine receptor; Autoimmunity; Experimental autoimmune myasthenia gravis

Indexed keywords

CHOLINERGIC RECEPTOR; MESSENGER RNA; RECEPTOR ANTIBODY;

AGED; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; TARGET ORGAN;

AGING; ANIMALS; ANTIBODIES, MONOCLONAL; AUTOIMMUNITY; BIOPSY; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; MUSCLE DENERVATION; MUSCLE, SKELETAL; MYASTHENIA GRAVIS; NEUROMUSCULAR JUNCTION; RATS; RATS, INBRED BN; RECEPTORS, CHOLINERGIC; RNA, MESSENGER; SCIATIC NERVE; SYNAPSES; UP-REGULATION;

EID: 18144442395     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00126-X     Document Type: Article

References (46)

1. Asher O., Fuchs S., Zuk D., Rapaport D., Buonanno A. Changes in the expression of mRNAs for myogenic factors and other muscle-specific proteins in experimental autoimmune myasthenia gravis. FEBS Lett. 299:1992;15-18.
2. Asher O., Kues W., Witzemann V., Tzartos S., Fuchs S., Souroujon M. Increased gene expression of acetylcholine receptor and myogenic factors in passively transferred experimental autoimmune myasthenia gravis. J. Immunol. 151:1993;6442-6450.
3. Asher O., Neumann D., Fuchs S. Increased levels of acetylcholine receptor α-subunit mRNA in experimental autoimmune myasthenia gravis. FEBS Lett. 233:1988;277-281.
4. Asher O., Neumann D., Witzemenn V., Fuchs S. Acetylcholine receptor gene expression in experimental autoimmune myasthenia gravis. FEBS Lett. 267:1990;231-235.
5. Asher O., Provenzano C., Fuchs S. Regulation of acetylcholine receptor gene expression in rats treated with α-bungarotoxin. FEBS Lett. 282:1991;242-246.
6. Chang C.C., Huang M.C. Turnover of junctional and extrajunctional acetylcholine receptors of the rat diaphragm. Nature. 253:1975;643-644.
7. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
8. Courtney J., Steinbach J. Age changes in neuromuscular junction morphology and acetylcholine receptor distribution on rat skeletal muscle fibres. J. Physiol. 320:1981;435-447.
9. Drachman B. Myasthenia gravis. New Engl. J. Med. 330:1994;1797-1810.
10. Duclert A., Changeux J.-P. Acetylcholine receptor gene expression at the developing neuromuscular junction. Physiol. Rev. 75:1995;339-368.
11. Duclert A., Piette J., Changeux J.-P. Influence of innervation on myogenic factors and acetylcholine receptor α-subunit mRNA's. NeuroReport. 2:1991;25-28.
12. Elmqvist D., Hofman W., Kugelberg J., Quastel D. An electrophysiological investigation of neuromuscular transmission in myasthenia gravis. J. Physiol. 174:1964;417-434.
13. Fontaine B., Sassoon D., Buckingham M., Changeux J.-P. Detection of the nicotinic acetylcholine receptor α-subunit mRNA by in situ hybridization at neuromuscular junctions of 15-day-old chick straited muscles. EMBO J. 7:1988;603-609.
14. Froehner S. Peripheral proteins of postsynaptic membranes from Torpedo electric organ identified with monoclonal antibodies. J. Cell Biol. 99:1984;88-96.
15. Garchon H.-J., Djabiri F., Viard J.-P., Gajdos P., Bach J.-F. Involvement of human muscle acetylcholine receptor α-subunit gene (CHRNA) in susceptibility to myasthenia gravis. Proc. Natl. Acad. Sci. U.S.A. 91:1994;4668-4672.
16. Graus Y.M.F., Verschuuren J.J.G.M., Spaans F., Jennekens F., van Breda Vriesman P.J.C., De Baets M.H. Age-related resistance to experimental autoimmune Myasthenia Gravis in rats. J. Immunol. 150:1993;4093-4103.
17. Guyon T., Levasseur P., Truffault F., Cottin C., Gaud C., Berrih-Aknin S. Regulation of acetylcholine receptor α-subunit variants RNA in human myasthenia gravis. Quantification of steady-state levels of messenger RNA in muscle biopsy using the polymerase chain reaction. J. Clin. Invest. 94:1994;16-24.
18. Hall Z., Sanes J. Synaptic structure and development: the neuromuscular junction. Cell. 72:1993;99-121.
19. Hoedemaekers A., Graus Y., Beijleveld L., van Breda Vriesman P., De Baets M. Macrophage infiltration at the neuromuscular junction does not contribute to AChR loss and age-related resistance to EAMG. J. Neuroimmunol. 75:1997;147-155.
20. Hoedemaekers A., Graus Y., van Breda Vriesman P., De Baets M. Age- and sex-related resistance to experimental autoimmune myasthenia gravis in Brown Norway rats. Clin. Exp. Immunol. 107:1997;189-197.
21. Hoedemaekers A., Verschuuren J., Spaans F., Graus Y., Riemersma S., Van Breda Vriesman P., De Baets M. Age-related susceptibility to experimental autoimmune myasthenia gravis: immunological and electrophysiological aspects. Muscle Nerve. 20:1997;1091-1101.
22. James M., Man Nt., Wise C., Jones G., Morris G. Utrophin-dystroglycan complex in membranes of adherent cultured cells. Cell Motil. Cytoskeleton. 33:1996;163-174.
23. Klarsfeld A., Bessereau J.-L., Salmon A.-M., Triller A., Babinet C., Changeux J.-P. An acetylcholine receptor α-subunit promotor conferring preferential synaptic expression in muscle of transgenic mice. EMBO J. 10:1991;625-632.
24. Konstatinides K., Rasure J. The Khoros software development environment for image and signal processing. IEEE Trans. Image Proc. 3:1994;243-252.
25. Lang T., Badea T., Wade R., Shin M. Sublytic terminal complement attack on myotubes decreases the expression of mRNAs encoding muscle specific proteins. J. Neurochem. 68:1997;1581-1589.
26. Lennon V., Lindstrom J., Seybold M. Experimental autoimmune myasthenia: a model of myasthenia gravis in rats and guinea pigs. J. Exp. Med. 141:1975;1365-1375.
27. Lindstrom J., Seybold M., Lennon V., Whittingham S., Duane D. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates and diagnostic value. Neurology. 26:1976;1054-1059.
28. Lindstrom J.M., Lennon V.A., Seybold M.E., Whittingham S. Experimental autoimmune Myasthenia Gravis and Myasthenia Gravis: Biochemical and immunochemical aspects. Ann. NY Acad. Sci. 274:1976;254-274.
29. 33P -labeled probes J. Histochem. Cytochem. 42:1994;1407-1411.
30. Loutrari L., Kokla A., Tzartos S.J. Passive transfer of experimental myasthenia gravis via antigenic modulation of acetylcholine receptor. Eur. J. Immunol. 22:1992;2449-2452.
31. Noakes P., Gautam M., Mudd J., Sanes J., Merlie J. Aberrant differentiation of neuromuscular junctions in mice lacking s-laminin/laminin β2. Nature. 374:1995;258-262.
32. Porter B., Sanes J. Gated migration: neurons migrate on but not onto substrates containing s-laminin. Dev. Biol. 167:1995;609-616.
33. Raats, C.J.I., Bakker, M.A.H., Hoch, W., Tamboer, W.P.M., Groffen, A.J.A., van den Heuvel, L.P.W.J., Berden, J.H.M., van den Born, J., 1998. Differential expression of agrin in renal basement membranes as revealed by domain-specific antibodies. J. Biol. Chem., in press.
34. Reist N., Werle M., McMahan U. Agrin released by motor neurons induces the aggregation of acetylcholine receptors at neuromuscular junctions. Neuron. 8:1992;865-868.
35. Roses A., Olanow W., McAdams M., Lane R. No direct correlation between serum antiacetylcholine receptor antibody levels and clinical state of individual patients with myasthenia gravis. Neurology. 31:1981;220-224.
36. Sandrock A., Dryer S., Rosen K., Gozani S., Kramer R., Theill L., Fischbach G. Maintenance of acetylcholine receptor number by neuregulins at the neuromuscular junction in vivo. Science. 276:1997;599-603.
37. Sanes J. The synaptic cleft of the neuromuscular junction. Dev. Biol. 6:1995;163-173.
38. Shinitzky M., Barenholz Y. Fluidity parameters of lipid regions determined by fluorescence polarization. Biochim. Biophys. Acta. 515:1978;367.
39. Stalberg E., Ekstedt J., Broman A. Neuromuscular transmission in myasthenia gravis studied with single fiber electromyography. J. Neurol. Neurosurg. Psychiatry. 37:1974;540-547.
40. Toyka K.V., Drachman D.B., Pestronk A., Kao I. Myasthenia Gravis: passive transfer from man to mouse. Science. 190:1975;397-399.
41. Tzartos S., Hochschwender S., Vasquez P., Lindstrom J. Passive transfer of experimental autoimmune myasthenia gravis by monoclonal antibodies to the main immunogenic region of the acetylcholine receptor. J. Neuroimmunol. 15:1987;185-194.
42. Tzartos S.J., Barkas T., Cung M.T., Kordossi A., Loutrari H., Marraud M., Papadouli I., Sakarellos C., Sophianos D., Tsikaris V. The main immunogenic region of the acetylcholine receptor. Structure and role in Myasthenia Gravis. Autoimmunity. 8:1991;259-270.
43. Verschuuren J., Spaans F., De Baets M. Single-fiber electromyography in experimental autoimmune Myasthenia Gravis. Muscle Nerve. 13:1990;485-492.
44. Verschuuren J.J.G.M., Graus Y.M.F., Theunissen R.O.M., Yamamoto T., Vincent A., van Breda Vriesman P.J.C., De Baets M.H. Role of acetylcholine receptor antibody complexes in muscle in experimental autoimmune Myasthenia Gravis. J. Neuroimmunol. 36:1992;117-125.
45. Wilson S., Vincent A., Newsom-Davis J. Acetylcholine receptor turnover in mice with passively transferred myasthenia gravis: I. Receptor degradation. J. Neurol. Neurosurg. Psychiatry. 46:1983;377-382.
46. Wokke J., Jennekens F., van den Oord C., Veldman H., Smit L., Leppink G. Morphological changes in the human end plate with age. J. Neurol. Sci. 95:1990;291-310.